Correlation Between Kaynes Technology and Mangalam Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kaynes Technology and Mangalam Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kaynes Technology and Mangalam Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kaynes Technology India and Mangalam Drugs And, you can compare the effects of market volatilities on Kaynes Technology and Mangalam Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kaynes Technology with a short position of Mangalam Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kaynes Technology and Mangalam Drugs.

Diversification Opportunities for Kaynes Technology and Mangalam Drugs

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Kaynes and Mangalam is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Kaynes Technology India and Mangalam Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangalam Drugs And and Kaynes Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kaynes Technology India are associated (or correlated) with Mangalam Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangalam Drugs And has no effect on the direction of Kaynes Technology i.e., Kaynes Technology and Mangalam Drugs go up and down completely randomly.

Pair Corralation between Kaynes Technology and Mangalam Drugs

Assuming the 90 days trading horizon Kaynes Technology India is expected to generate 0.8 times more return on investment than Mangalam Drugs. However, Kaynes Technology India is 1.25 times less risky than Mangalam Drugs. It trades about 0.16 of its potential returns per unit of risk. Mangalam Drugs And is currently generating about 0.01 per unit of risk. If you would invest  562,265  in Kaynes Technology India on October 19, 2024 and sell it today you would earn a total of  95,725  from holding Kaynes Technology India or generate 17.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kaynes Technology India  vs.  Mangalam Drugs And

 Performance 
       Timeline  
Kaynes Technology India 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Kaynes Technology India are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Kaynes Technology sustained solid returns over the last few months and may actually be approaching a breakup point.
Mangalam Drugs And 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Kaynes Technology and Mangalam Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kaynes Technology and Mangalam Drugs

The main advantage of trading using opposite Kaynes Technology and Mangalam Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kaynes Technology position performs unexpectedly, Mangalam Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangalam Drugs will offset losses from the drop in Mangalam Drugs' long position.
The idea behind Kaynes Technology India and Mangalam Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities